2-Methyl-N-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]benzamide

Catalog No. :
ACCXRZ192
CAS No. :
439094-92-5
Molecular Formula :
C18H22N4O
Molecular Weight :
310.40

IUPAC Name:2-methyl-N-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)benzamide

2-Methyl-N-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-N-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]benzamide
IUPAC Name2-methyl-N-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)benzamide
MDL No.MFCD03012851
Molecular FormulaC18H22N4O
Molecular Weight310.40
SMILESO=C(NC1=CC=C(N2CCN(C)CC2)N=C1)C3=CC=CC=C3C
InChI KeyGMDOCSOSEKSTBI-UHFFFAOYSA-N
Synonym2-METHYL-N-[6-(4-METHYLPIPERAZINO)-3-PYRIDINYL]BENZENECARBOXAMIDE;2-methyl-N-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]benzamide;Benzamide, 2-methyl-N-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-
CAS No.439094-92-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCXRZ192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUEXV761 route compound structure diagram
    ACUEXV76155403-35-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCXRZ192 route product structure diagram
    ACCXRZ192439094-92-5
Inquiry

2. ACCXRZ192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUEXV761 route compound structure diagram
    ACUEXV76155403-35-5 In Stock
  2. Plus
  3. ACKAWX936 route compound structure diagram
    ACKAWX936118-90-1 In Stock
  4. Then
  5. ACCXRZ192 route product structure diagram
    ACCXRZ192439094-92-5
Inquiry

Comments (0)